Is the $140 headline price real?

Yes, and that is unusual enough to be the main reason this service is listed. $140/month is the genuine month-to-month price of the low-dose injectable semaglutide and low-dose injectable tirzepatide programs — not a twelve-month rate, not a prepay figure. The standard programs are $179 for injectable semaglutide, $199 for oral semaglutide and $249 for injectable tirzepatide, each also quoted monthly first, with 12-, 24- and 52-week totals beside them. Plenty of services here lead with a prepay rate instead.

Does No BS RX sell peptides?

No, deliberately. It publishes a page titled "sketchy peptides" arguing against the way the category is sold, and commits on its About page to not using research-grade or gray-market peptide sources. If you want sermorelin, NAD⁺ or BPC-157 alongside a GLP-1, this is not the service — Idgie Health and the RX Bella cluster sell both, and Renlo Health sells NAD⁺ and glutathione.

Can I start the sleep program?

Not yet. The sleep pages publish the full program — an FDA-cleared diagnostic ring, a 3–5 night at-home study read by a board-certified clinician, therapy consults and medication support — with every price attached, but the program itself carries a "Coming Soon" banner and the site states: "The sleep program isn't open yet… We'd rather show you that now than take your details for something we can't schedule yet." That is a more honest handling of a pre-launch service than most, but it is not something you can book today.

Which pharmacy does No BS RX use?

It does not say. The service commits to state-licensed 503A compounding pharmacies, pharmaceutical-grade active ingredients from FDA-registered manufacturers, and a Certificate of Analysis from any pharmacy partner — genuinely stronger sourcing language than most of this board uses — but names no facility, so none of it can be checked. If a named pharmacy matters to you, Rx.com names Manifest Pharmacy with a street address and Idgie Health names VialsRX with one.

No BS RX is a GLP-1 telehealth service you reach through an online questionnaire and an online intake a clinician reviews. The medications it names are Compounded semaglutide and Compounded tirzepatide. What it publishes up front: Semaglutide $179/mo, tirzepatide $249, low-dose either at $140; no dose-based increases; 503A stated. It is cash-pay and states it does not bill insurance. It displays a LegitScript certification claim, which we record as a claim and not as a verified fact: LegitScript's public checker is gated and returns the same page for any domain put into it, so no one can reproduce a check from it. What our record does not establish: which states it serves. Ask for those in writing before you pay.

Is No BS RX expensive compared with other GLP-1 telehealth providers?

No BS RX publishes a starting figure of $140/mo. Across the 52 GLP-1 telehealth providers we review that publish a single monthly figure, those run $49 to $269 with a median of $179, which puts No BS RX below the median, toward the cheaper end. The other 31 GLP-1 telehealth providers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.

Updated September 2026

No BS RX review

Headline is the real price

Its advertised price is also the price you pay in month one — which almost nothing else here can say.

Our verdict

No BS RX builds its whole proposition on the failure this board documents over and over — a headline price that is really a prepay rate — and then doesn't commit it. Every program is tabled at monthly, 12-, 24- and 52-week lengths with the monthly rate first, and the $140 in the banner is the genuine monthly price of its low-dose programs. It commits in writing to 503A-only fulfillment, pharmaceutical-grade ingredients and a Certificate of Analysis. The gap is who stands behind it: neither the pharmacy nor the medical group is named anywhere. Its sleep program is fully priced but isn't open yet, and it says so itself rather than taking your details for it.

Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. Partners are listed first; a commission never changes what we write about a provider. How we make money.

Check availability →Semaglutide $179/mo, tirzepatide $249, low-dose either at $140; no dose-based increases; 503A stated

At a glance

Category: GLP-1 telehealth
Access: Semaglutide $179/mo, tirzepatide $249, low-dose either at $140; no dose-based increases; 503A stated
Medications: Compounded semaglutide · Compounded tirzepatide
Insurance: Cash-pay, no insurance
Visit: Quiz intake / Async intake
Availability: Not published
LegitScript: Claimed by provider
Updated: September 2026

What it is

A GLP-1 weight-loss service positioned explicitly against the marketing practices of its own category — its feature pages are titled bait-and-switch, hidden pricing, fake claims, MLM markups and sketchy peptides. It sells compounded semaglutide (injectable and oral) and compounded tirzepatide, in standard and low-dose programs, and provides administrative support around provider-guided care rather than practicing medicine itself. Its LegitScript seal id resolves against the issuer. A second track, an at-home sleep-apnea program delivered with OpenLoop and Happy Sleep, is published but not open.

How it works

Asynchronous, through an online intake with licensed provider review and a Tellescope patient portal. The service is direct about limits — it does not guarantee approvals, and states that providers will say so if you are not a good fit. Its sourcing commitments are unusually specific for this category: 503A state-licensed compounding pharmacies only, pharmaceutical-grade active ingredients from FDA-registered manufacturers, and no partnership with a pharmacy that cannot supply a Certificate of Analysis. ⚠ None of those partners is named, and no list of states served is published, so the commitments are verifiable in principle and not in practice.

Pricing transparency

Pricing is the clearest thing about this service. Standard programs: semaglutide injectable $179/month, oral semaglutide $199/month, tirzepatide injectable $249/month. Low-dose programs: oral semaglutide $179, injectable semaglutide $140, injectable tirzepatide $140. Each carries its 12-week, 24-week and 52-week totals beside the monthly rate — semaglutide injectable runs $499, $999 and $1,899 — and every card repeats "no dose-based price changes." The $140 in the banner is the real monthly price of the low-dose programs, not a prepay rate, which makes this the only service in the batch whose headline survives the check. The sleep program publishes a cash price of $33/month billed as $396 annually for the diagnostic ring, $149 per therapy consult or $129 in a six-consult block, and $33–$63/month for sleep medication — for a program that is not yet accepting patients.

Branded vs compounded

Compounded semaglutide and compounded tirzepatide, injectable and oral, at a flat price per program rather than per dose. On the evidence: the semaglutide and tirzepatide outcome data belongs to the branded products, and compounded copies are not FDA-approved and are not assessed by the FDA for potency, purity or consistency — which is why the Certificate of Analysis and pharmaceutical-grade API commitments are worth more here than the usual reassurance that a pharmacy is "licensed." ⛔ It sells no peptides at all, and argues against the category on its own site; do not come here for sermorelin, NAD⁺ or testosterone.

Pros and watch-outs

What we like

The advertised price is the month-to-month price, not a prepay rate
Every program tabled at monthly, 12-, 24- and 52-week lengths, with no dose-based increases
Commits in writing to 503A-only fulfillment, pharmaceutical-grade APIs and a Certificate of Analysis requirement
States plainly that it does not guarantee approvals and will turn people down
LegitScript seal id resolves against the issuer

Watch-outs

Neither the dispensing pharmacy nor the medical group is named anywhere
No list of states served published
The sleep program is fully priced and marketed but is not open to patients yet
Sells no peptide, NAD⁺ or hormone therapy, so it cannot be a single-service option

Best for

Buyers who want to know the real monthly cost before intake and care more about sourcing commitments than about brand polish.

Who should look elsewhere

Anyone who needs the pharmacy named, wants peptides or hormone care alongside a GLP-1, or is shopping for the sleep program today.

The evidence behind what No BS RX prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

What the semaglutide weight-loss trials actually showed
STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.
Tirzepatide vs semaglutide for weight loss: what the trials actually support
Most comparisons are cross-trial. Only SURPASS-2 and SURMOUNT-5 randomized one drug against the other — here's the precise distinction.
Oral semaglutide (Rybelsus): what the PIONEER trials actually showed
A GLP-1 peptide in a pill is hard to pull off. PIONEER 1, 4, and 6 plus OASIS 1 — read straight from the primary literature.

How No BS RX compares

A few alternatives worth a look, depending on what you’re optimizing for.

Renlo Health
A flat monthly GLP-1 price with the provider group, pharmacy and 503A basis all named
See Renlo Health →
Rx.com
Buyers who want the pharmacy, the provider network and the boxed warning all published up front
See Rx.com →
Idgie Health
One menu covering GLP-1, NAD⁺, sermorelin and hair care with the pharmacy named
See Idgie Health →

Compare all providers side by side →

More GLP-1 telehealth reviews: HumeCare+Try AgelessSkinnyRxPeter MDMadeMedShed

Nadia Feldman

Access & cost · Reviewed and last verified September 2026

How we assessed this. This review reflects Aminoscope’s own read of No BS RX’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.

Frequently asked

Is the $140 headline price real?: Yes, and that is unusual enough to be the main reason this service is listed. $140/month is the genuine month-to-month price of the low-dose injectable semaglutide and low-dose injectable tirzepatide programs — not a twelve-month rate, not a prepay figure. The standard programs are $179 for injectable semaglutide, $199 for oral semaglutide and $249 for injectable tirzepatide, each also quoted monthly first, with 12-, 24- and 52-week totals beside them. Plenty of services here lead with a prepay rate instead.
Does No BS RX sell peptides?: No, deliberately. It publishes a page titled "sketchy peptides" arguing against the way the category is sold, and commits on its About page to not using research-grade or gray-market peptide sources. If you want sermorelin, NAD⁺ or BPC-157 alongside a GLP-1, this is not the service — Idgie Health and the RX Bella cluster sell both, and Renlo Health sells NAD⁺ and glutathione.
Can I start the sleep program?: Not yet. The sleep pages publish the full program — an FDA-cleared diagnostic ring, a 3–5 night at-home study read by a board-certified clinician, therapy consults and medication support — with every price attached, but the program itself carries a "Coming Soon" banner and the site states: "The sleep program isn't open yet… We'd rather show you that now than take your details for something we can't schedule yet." That is a more honest handling of a pre-launch service than most, but it is not something you can book today.
Which pharmacy does No BS RX use?: It does not say. The service commits to state-licensed 503A compounding pharmacies, pharmaceutical-grade active ingredients from FDA-registered manufacturers, and a Certificate of Analysis from any pharmacy partner — genuinely stronger sourcing language than most of this board uses — but names no facility, so none of it can be checked. If a named pharmacy matters to you, Rx.com names Manifest Pharmacy with a street address and Idgie Health names VialsRX with one.
Is No BS RX legit?: No BS RX is a GLP-1 telehealth service you reach through an online questionnaire and an online intake a clinician reviews. The medications it names are Compounded semaglutide and Compounded tirzepatide. What it publishes up front: Semaglutide $179/mo, tirzepatide $249, low-dose either at $140; no dose-based increases; 503A stated. It is cash-pay and states it does not bill insurance. It displays a LegitScript certification claim, which we record as a claim and not as a verified fact: LegitScript's public checker is gated and returns the same page for any domain put into it, so no one can reproduce a check from it. What our record does not establish: which states it serves. Ask for those in writing before you pay.
Is No BS RX expensive compared with other GLP-1 telehealth providers?: No BS RX publishes a starting figure of $140/mo. Across the 52 GLP-1 telehealth providers we review that publish a single monthly figure, those run $49 to $269 with a median of $179, which puts No BS RX below the median, toward the cheaper end. The other 31 GLP-1 telehealth providers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.

Check availability →

Or compare every GLP-1 provider.